FDA unveils plans for "off-label" mailings

被引：0

作者：

不详

机构：

来源：

ONCOLOGY-NEW YORK | 1998年 / 12卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：968 / 968

页数：1

共 50 条

[1] FDA SCRUTINIZES OFF-LABEL PROMOTIONS
RANDALL, T
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (01): : 11 - 11
[2] FDA off-track on off-label drug promotion
不详
[J]. LANCET, 2007, 370 (9604): : 1976 - 1976
[3] FDA publishes final rule on off-label information
Barlas, S
[J]. ONCOLOGY-NEW YORK, 1999, 13 (02): : 150 - 150
[4] From off-label prescribing towards a new FDA
Tabarrok, Alex
[J]. MEDICAL HYPOTHESES, 2009, 72 (01) : 11 - 13
[5] Off-label reprints still a hot issue in FDA reform
Kreeger, KY
[J]. SCIENTIST, 1997, 11 (02): : 1 - &
[6] US FDA ordered to allow off-label data dissemination
Ault, A
[J]. LANCET, 1998, 352 (9127): : 555 - 555
[7] FDA Regulation of Off-label Drug Promotion Under Attack
Kesselheim, Aaron S.
Mello, Michelle M.
Avorn, Jerry
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (05): : 445 - 446
[8] Court rules that FDA cannot restrict off-label marketing
Roehr, Bob
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
[9] FDA recommends against off-label sildenafil use in children
[J]. Reactions Weekly, 2012, 1418 (1) : 2 - 2
[10] Regulating off-label drug use - Rethinking the role of the FDA
Stafford, Randall S.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14): : 1427 - 1429